ZJAMP.(SZ:002758) Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2025-10-21 10:51Transaction Overview - The company has approved the transfer of 100% equity of its wholly-owned subsidiary, Zhejiang Huato Medicine Group Co., Ltd. (Huato Medicine), through a public listing on the Zhejiang Property Exchange to optimize resource allocation and enhance operational efficiency [2] - The total equity value of Huato Medicine is assessed at 369.0952 million yuan, with an appreciation of 186.4005 million yuan, resulting in an appreciation rate of 102.03% [2] Transaction Progress - The equity transfer project was first listed on the Zhejiang Property Exchange on May 20, 2025, and Zhejiang Yinte Pharmaceutical Co., Ltd. successfully acquired it for 369.10 million yuan [3] - On May 30, 2025, the company signed the equity transaction contract with Yinte Pharmaceutical [3] - The National Market Supervision Administration issued a decision not to prohibit the acquisition, allowing Yinte Pharmaceutical to proceed with the transaction [4] Additional Information - The transaction requires both parties to complete payment, property transfer, and related business changes as per the transaction contract [5] - The company will fulfill its information disclosure obligations based on the progress of the transaction [5]